SCHEMBL6818261

SCHEMBL6818261

O=C(Nc1ccc(Cl)cc1C(=O)O)c1cc(-c2ccc(C(F)(F)F)cc2)on1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.56
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
NPC1 O15118 4/20 0.54
RAB9A P51151 3/20 0.54
MAPT P10636 2/20 0.54
XBP1 P17861 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
SERPINE1 P05121 2/20 0.53
TRPV1 Q8NER1 1/20 0.53
ACR P10323 1/20 0.53
TP53 P04637 2/20 0.52
LMNA P02545 1/20 0.52
RXFP1 Q9HBX9 1/20 0.52
KCNK2 O95069 1/20 0.51
KCNK10 P57789 1/20 0.51
PPARG P37231 1/20 0.51
PPARD Q03181 1/20 0.51
NR1H4 Q96RI1 1/20 0.51
FAAH O00519 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6813720 0.88 MEN1 (0.55) THRBMEN1KMT2ANPC1RAB9A
SCHEMBL6818030 0.86 MEN1 (0.66) THRBMEN1KMT2ANPC1MAPT
SCHEMBL6821776 0.85 NPC1 (0.51) THRBMEN1KMT2ANPC1RAB9A
SCHEMBL6833098 0.83 MEN1 (0.73) THRBMEN1KMT2ANPC1RAB9A
SCHEMBL6821659 0.82 NPC1 (0.62) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL6830546 0.78 KMT2A (0.53) THRBMEN1KMT2ANPC1RAB9A
SCHEMBL6833999 0.77 NPC1 (0.61) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL4398685 0.77 ALDH1A1 (0.66) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL418647 0.75 SERPINE1 (0.66) RAB9ASERPINE1KCNK2KCNK10PPARG
SCHEMBL6835638 0.75 STAT3 (0.58) MEN1KMT2ANPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed
WO-2004018428-A1 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 THRB 4330/4885MEN1 4132/4885KMT2A 2853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.